Syntax is the only two-sided SaaS actuarial platform that enables and scales VBC adoption. It offers advanced analytics and a real-time collaborative workspace where myriad stakeholders (actuaries, analysts, network managers, providers) engage in modeling and negotiation. 

• eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens.
• eCART received FDA 510(k) clearance in 2024, with clinical performance data of nearly two million hospitalizations from 21 hospitals, including an unprecedented level of real-world prospective data, to ensure consistent accuracy across geography, age, race, and top medical conditions (e.g. sepsis, COPD, heart failure). 
• Built upon more than a decade of ongoing scientific research, eCART was developed at UChicago Medicine by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

N/A

Syntax offers something entirely new: actuarially credible program design and contract modeling capabilities coupled with transparent, collaborative contract negotiations via our 2-sided workspace. Most solutions in this space are focused on care coordination or population health.

How we're different:  

• Our SaaS enterprise solution facilitates open, candid, real-time discussions that break down barriers posed by physical distance, lack of trust, or apprehension over the risks associated with implementing a new value-based care model. 
• Syntax deploys a team-based approach in which everyone can view savings, spend and the direct impact on outcomes/efficiency that different models have. 
• We enable teams to model contract terms and incentive scenarios using our fast-track templates or they can configure their own using our dynamic model builder. 
• Syntax also provides the ability to refresh performance measurement on demand, allowing team members to preview emerging trends for course correction and value alignment.
• We delight customers by automating tasks often done in cumbersome, time-consuming ways.
• Syntax saves time, removes redundant tasks and improves efficiency.

• Continuously monitors EHR data in real time
• Stratifies hospitalized patients by risk of impending all-cause clinical deterioration and sepsis
• Notifies inpatient providers when patient may need additional assessment and management
• Recommends clinical pathways with integrated order entry

• Authorized: FDA 510(k) cleared
• Tested: Derived and validated in nearly 3 million patient encounters across 28 hospitals
• Experienced: 8+ years in clinical use; 10+ years of published academic literature on value over other early warning scores
• Accurate: High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated: Embedded cross-team workflow ensures that risk scores are not ignored and action is taken
• Benchmarked: Robust reporting, benchmarking, and implementation support drive quality improvement